Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hemolytic-Uremic

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hemolytic-Uremic:

Pubmed Logo
Predictors of complications in therapeutic plasma exchange.
Plasma exchange (PE) is used for blood purification to modulate proteins...
6th November, 2009
Department of Medicine, Nephrology and Rheumatology, J Clin Apher. 2009 Nov 3.
DOI Direct Link
Etiology and outcome of acute renal failure in pregnancy.
Objective: To determine the etiology and outcome of Acute Renal Failure...
6th November, 2009
Department of Nephrology, Jinnah Postgraduate Medical Centre, Karachi. J Coll Physicians Surg Pak. 2009 Nov;19(11):714-7.
DOI Direct Link
Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead either to altered secretion or altered function of factor I.
The complement system is regulated by inhibitors such as factor I (FI), a...
31st October, 2009
Department of Laboratory Medicine, Medical Protein Chemistry, Malmo Eur J Immunol. 2009 Oct 28.
DOI Direct Link
Atypical hemolytic-uremic syndrome.
Kidney transplant in patients with atypical hemolytic uremic syndrome...
30th October, 2009
Clinical Research Center for Rare Diseases Aldo e Cele Dacco, Mario Negri N Engl J Med. 2009 Oct 22;361(17):1676-87.
DOI Direct Link
Severe atypical HUS caused by CFH S1191L-case presentation and review of treatment options.
Atypical hemolytic uremic syndrome (aHUS) has been associated with...
27th October, 2009
Division of Nephrology, The Hospital for Sick Children, 555 University Pediatr Nephrol. 2009 Oct 24.
DOI Direct Link

View more research publications.

Press Releases About Hemolytic-Uremic:

BioPortfolio Logo
Reportlinker Adds Immunotherapies and Vaccines for Nontraditional Indications 26th October, 2009 Reportlinker
NEW YORK, Oct. 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Immunotherapies and Vaccines for Nontraditional
New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Hepatitis C Virus And Therapeutics Market http://www.reportlinker.com/p0119497/World
Bioniche Invited to Participate in Canadian Beef Value Chain Roundtable 3rd February, 2009 Bioniche Life Sciences Inc.
- President of Bioniche Food Safety an invited speaker - BELLEVILLE, ON, Feb. 3 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting 7th December, 2008 Alexion Pharmaceuticals, Inc.
CHESHIRE, Conn., Dec. 7 /PRNewswire-FirstCall/-- Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) for the treatment of paroxysmal
GeneThera Releases Results From Initial Animal Tests of E.Coli O157:h7 Vaccine Amid News of Increase of E.Coli Discoveries in Beef Products 17th November, 2008 GeneThera, Inc.
WHEAT RIDGE, Colo., Nov. 17 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), today released information about its E.Coli O157:H7 vaccine. The vaccine consists of Live Attenuated

BioNews Results for Hemolytic-Uremic:

RSS Logo
BioPortfolio Logo
Alexion Pharmaceuticals to Present Soliris Data at Annual ASH Meeting
TradingMarkets:  Nov 13 2009 5:28AM Matching: hemolytic uremic
Researchers to Present Additional Data on Soliris (eculizumab) for the Treatment of Patients With PNH at the A
Pharma Live:  Nov 12 2009 12:03AM Matching: hemolytic uremic
Researchers To Present Additional Data On Soliris(R) (eculizumab) For The Treatment Of Patients With PNH At Th
Medical News Today:  Nov 12 2009 6:19AM Matching: hemolytic uremic
Alexion Pharmaceuticals Inc. (ALXN) Release: Researchers to Present Additional Data on Soliris(R) (eculizumab)
BioSpace:  Nov 11 2009 7:45PM Matching: hemolytic uremic
Researchers to Present Additional Data on Soliris (eculizumab) for the Treatment of Patients With PNH at the
Freshnews.com:  Nov 11 2009 1:49AM Matching: hemolytic uremic
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Hemolytic-Uremic Patents:

USPTO Logo
US Patent No.Title
7399613 Sialic acid nucleotide sugars
7465707 Methods of treatment with TR10 polypeptides
7468419 Cyclosporin derivatives for the treatment of immune disorders
7476384 Death domain containing receptor 4 antibody and methods
7479504 Edg receptor agonists

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hemolytic-Uremic scientists - we have details of around 440 individuals working on Hemolytic-Uremic .


This page has been viewed 356 times
Recent Search Terms used to find this page: eculizumab trials and atypical HUS | Soliris new October 2009 | 2009 reserch uremia | Hemolytic uremic syndrome, 2008, 2009 | Hemolytic uremic syndrome, 2008, 2009 | Soliris for atypical hus | Soliris for atypical hus | use of soliris in patients with HUS | atypical hus clinical trial | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hemolytic-Uremic across BioPortfolio, or for Hemolytic-Uremic Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.